Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
106-120 of 2102 results
Servier exercises option to buy rights to Cellectis' UCART19 immunotherapy candidate
By PBR Staff Writer
Servier has exercised its option with Cellectis to acquire exclusive worldwide rights to UCART19, a TALEN gene-edited allogeneic chimeric antigen receptor T-cell (CAR-T) immunotherapy.
Contract Research & Services > Contract Research > News
Teva, University College London start brain imaging study to treat neurodegenerative diseases
By PBR Staff Writer
Teva Pharmaceutical Industries and University College London (UCL) have started a brain-imaging study to uncover a new approach in neurodegenerative disease.
Contract Research & Services > Contract Research > News
Ipsen, Interprotein partner to develop new therapeutic peptides in endocrinology
By PBR Staff Writer
Ipsen and Interprotein have partnered to develop and commercialize new therapeutic peptides in endocrinology.
Contract Research & Services > Contract Research > News
Turing Pharmaceuticals inks research deal with University of Toledo for canavan disease
Turing Pharmaceuticals has signed a sponsored research agreement with the University of Toledo to discover and develop new treatments for Canavan Disease.
Contract Research & Services > Contract Research > News
Cerulean, AstraZeneca and NCI to assess efficacy of CRLX101 and Lynparza combination
By PBR Staff Writer
Cerulean Pharma, AstraZeneca and the National Cancer Institute (NCI) have agreed to collaborate on a clinical study to assess the combination of CRLX101 and Lynparza (olaparib) in patients with small cell lung cancer.
Contract Research & Services > Contract Research > News
ImmunoCellular signs sponsored research deal with University of Texas MD Anderson Cancer
ImmunoCellular Therapeutics has entered into a sponsored research agreement with Dr. Cassian Yee at the University of Texas MD Anderson Cancer Center.
Contract Research & Services > Contract Research > News
Beckman Coulter, IncellDx sign distribution deal for human papilloma virus research
Beckman Coulter Life Sciences and IncellDx have signed a distribution agreement which focuses exclusively on clinical researchers in mainland China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer.
Contract Research & Services > Contract Research > News
Hanmi inks license agreement with Janssen
By PBR Staff Writer
South Korea-based Hanmi Pharmaceutical has signed a license agreement with Janssen Pharmaceuticals to develop a new diabetes and obesity drug.
Contract Research & Services > Contract Research > News
Ignyta buys rights to taladegib oncology program from Eli Lilly
By PBR Staff Writer
Ignyta has secured an exclusive global license to Eli Lilly and Company's taladegib, an orally available small molecule hedgehog/smoothened antagonist under development to treat a range of cancers.
Contract Research & Services > Contract Research > News
CytomX, MD Anderson Cancer Center partner for probody-enabled CAR-NK cell therapies
CytomX Therapeutics has entered into a collaboration with the University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.
Contract Research & Services > Contract Research > News
Novo Nordisk, University of Washington start research collaboration
Novo Nordisk and University of Washington have started a collaboration to explore the role of the brain in regulating blood glucose and obesity.
Contract Research & Services > Contract Research > News
GSK and Merck start Phase I trial of GSK3174998 with Keytruda
By PBR Staff Writer
GlaxoSmithKline (GSK) and Merck are trialing a combination of two separate drugs as a potential cancer treatment.
Contract Research & Services > Contract Research > News
Boehringer Ingelheim, BioMed X extend COPD collaboration
By PBR Staff Writer
Boehringer Ingelheim and the BioMed X Innovation Center have extended their collaboration to discover novel therapeutic concepts for the treatment of psychiatric diseases.
Contract Research & Services > Contract Research > News
Ultragenyx, Arcturus sign messenger RNA therapeutics deal
By PBR Staff Writer
Ultragenyx Pharmaceutical has partnered with Arcturus Therapeutics to discover and develop messenger RNA (mRNA) therapeutics for rare disease targets.
Contract Research & Services > Contract Research > News
BioCision, UCSF partner to advance cell therapy for organ transplantation and diabetes
By PBR Staff Writer
BioCision has collaborated with the University of California, San Francisco (UCSF) to advance cell therapy for organ transplantation and diabetes.
Contract Research & Services > Contract Research > News
106-120 of 2102 results